SANMEDEX: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SANMEDEX
Largest movements
No asset line moved by more than 1% of the balance sheet total.
- Profit (loss) carried forward -€624
down €624 (-1.2%), from -€50,923 to -€51,547
- Trade debts +€548
up €548 (+60.2%), from €910 to €1,457
- Gross operating margin +€362
up €362 (+39.8%), from -€910 to -€548
- Financial charges -€354
down €354 (-82.3%), from €430 to €76
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €50,938 | €50,938 | = | 0.0% |
| Current assets | 29/58 | €50,938 | €50,938 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €50,938 | €50,938 | = | 0.0% |
| Trade receivables | 40 | €50,938 | €50,938 | = | 0.0% |
| Total equity and liabilities | 10/49 | €50,938 | €50,938 | = | 0.0% |
| Equity | 10/15 | -€37,223 | -€37,847 | -€624 | -1.7% |
| Contributions | 10/11 | €13,700 | €13,700 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€50,923 | -€51,547 | -€624 | -1.2% |
| Amounts payable | 17/49 | €88,161 | €88,785 | +€624 | +0.7% |
| Amounts payable within one year | 42/48 | €88,161 | €88,785 | +€624 | +0.7% |
| Financial debts | 43 | €492 | €568 | +€76 | +15.4% |
| Credit institutions | 430/8 | €492 | €568 | +€76 | +15.4% |
| Trade debts | 44 | €910 | €1,457 | +€548 | +60.2% |
| Suppliers | 440/4 | €910 | €1,457 | +€548 | +60.2% |
| Other amounts payable | 47/48 | €86,759 | €86,759 | = | 0.0% |
| Gross operating margin | 9900 | -€910 | -€548 | +€362 | +39.8% |
| Operating profit (loss) | 9901 | -€910 | -€548 | +€362 | +39.8% |
| Financial income | 75/76B | €0 | €0 | -€0 | -10.0% |
| Recurring financial income | 75 | €0 | €0 | -€0 | -10.0% |
| Financial charges | 65/66B | €430 | €76 | -€354 | -82.3% |
| Recurring financial charges | 65 | €430 | €76 | -€354 | -82.3% |
| Profit (loss) for the period before taxes | 9903 | -€1,340 | -€624 | +€716 | +53.4% |
| Profit (loss) for the period | 9904 | -€1,340 | -€624 | +€716 | +53.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€1,340 | -€624 | +€716 | +53.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.